1 January 2022 in Clinical and Experimental Vaccine Research
Purpose: Indonesia, a high populous and the second-highest country in epidemicity of hepatitis B in South-East Asia require maintaining its capacity of monovalent hepatitis B production to keep up with both the national immunization program and global needs. To keep the sustainability of the vaccine, a new bulk is needed to be made available. This study aims to evaluate the immunogenicity and safety of Bio Farma newly formulated recombinant hepatitis B vaccines, which came from different sources of bulk, compared to the already registered hepatitis B vaccine. Materials and Methods: An experimental, randomized, double-blind, cohort intervention phase II clinical trial was conducted on three recombinant hepatitis B vaccines from different bulk sources, with Bio Farma registered hepatitis B vaccine as the control group. A total of 536 participants around age 10 to 40 years old were thricely vaccinated with twice serological assessments. The subject's safety was monitored for 28 days after each vaccination. Results: Of 536 enrolled participants, 521 finished the vaccination and serology assessments. The investigational products were proven not to be inferior to the control. All vaccines were well tolerated. No differences in rates of local and systemic reactions were seen between the investigational products and control. No serious adverse event was found to be related to the investigational vaccines. Conclusion: Investigational vaccines are shown to be equally immunogenic and safe as the control vaccine.
1 February 2024 in The Open Public Health Journal
Introduction: We conducted a Phase I SARS-CoV-2 vaccine trial in March 2022. During the screening, we identified a significant number of asymptomatic COVID-19 cases among the candidate participants. We aimed to highlight the clinical characteristics among these asymptomatic individuals as compared to subjects negative for SARS-CoV-2. Methods: This observational study was conducted during participant screening for a Phase I SARS-CoV-2 vaccine trial in Jepara and Mranggen districts in Central Java, Semarang, Indonesia. Participants who reported no symptoms associated with COVID-19, confirmed by physical examinations, were included. Data on laboratory markers were documented. An asymptomatic case was defined as showing no clinical symptoms and signs of SARS-CoV-2 infection with a positive SARS-CoV-2 RT-PCR result. Individuals who tested negative for SARS-CoV-2 were included for comparison. A chi-square test was employed to assess the differences between the two groups, with a p-value 0.05) among individuals with positive and negative SARS-CoV-2. Conclusion: In our vaccine trial screening phase, almost half were ineligible due to having asymptomatic SARS-CoV-2 infections. In addition, it is necessary that people with asymptomatic COVID-19 infection still need to be concerned because they have the same transmission potential.
15 December 2025 in Diponegoro International Medical Journal
Background: The use of the internet among adolescents increases rapidly, particularly since COVID-19 pandemic, due to the necessity of online learning. Excessive internet use may progress to internet addiction, which has been identified as a risk factor for sleep disturbances. Sleep disorders that occur in adolescents may persist into adulthood, can result in sustained detrimental effects on health, especially in individuals aged 10-12 years, as they are still on critical period of growth and neurodevelopment. Data from Demak show that 30% from 40,000 students from elementary to high school have been addicted to online games, which represents a major subtype of internet addiction. Objective: To determine the relationship between internet addiction and sleep disorders among adolescents aged 10-12 years. Methods: A cross-sectional, analytical observational study was conducted. Data were obtained using the Internet Addiction Diagnostic Questionnaire questionnaire and the Sleep Disturbance Scale for Children (SDSC) questionnaire, administered to four grades and five grades at Bintoro 5 Elementary School in Demak, recruited through purposive sampling. Statistical analysis was performed using chi-square tests and multivariate logistic regression to control the confounding variables such as physical activity, obesity, and co-sleeping. Results: Among 81 respondents, the prevalence of internet addiction was 35.8% (n=29), and the prevalence of sleep disorders was 61.7% (n=50). Bivariate analysis using chi-square test demonstrated a significant relationship between internet addiction and sleep disorders P<0.05 (0.008). After controlling for confounding factors with logistic regression, the result remained statistically significant P<0.05 (0.006). Conclusion:Internet addiction is significantly associated with sleep disorders in adolescents aged 10-12 years, even after controlling for confounding factors.